Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The administration of VSL#3 TM effectively prevents and treats obesity and diabetes in several mouse models. VSL#3 was found to suppress body weight gain and insulin resistance by modulating the composition of gut microbiota. This probiotic also promoted the release of the hormone Glucagon Like Peptide 1 (GLP-1),(?id=4be5d59f-79be-50df-8091-f82934074b83&linkText=Glucagon+Like+Peptide+1+%28GLP-1%29) which led to reduced food intake and improved glucose tolerance (1).…